Chang David D
- SEC CIK
- 0001611024
In the past year, 2 open-market sale filings worth $289.5K and no purchases.
Current role at each company
- ALLO Allogene Therapeutics, Inc.President and CEOas of Mar 18, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $289.5K
- 2 filings
- Net
- −$289.5K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Chang David D as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 18, 2026 (view filing) | Mar 16 | 2 days | Chang David DPresident and CEO | SSale | −47.8K | $2.47 | −$118.0K | −0.9%5.15M after | |
| Feb 4, 2026 (view filing) | Feb 2 | 2 days | Chang David DPresident and CEO | SSale | −95.3K | $1.80 | −$171.5K | −1.8%5.19M after | |
| Mar 18, 2025 (view filing) | Mar 14 | 4 days | Chang David DPresident and CEO | SSale | −46.7K | $1.96 | −$91.5K | −0.9%5.28M after | |
| Feb 5, 2025 (view filing) | Feb 3 | 2 days | Chang David DPresident and CEO | SSale | −46.0K | $1.68 | −$77.3K | −0.9%5.32M after | |
| Mar 17, 2022 (view filing) | Mar 15 | 2 days | Chang David DPresident and CEO | SSale | −23.6K | $7.65 | −$180.9K | −1.0%2.29M after |